France Considering Ban on Disposable E-Cigarettes

May.04.2023
France Considering Ban on Disposable E-Cigarettes
France may ban disposable e-cigarettes by the end of 2023 as part of an anti-smoking plan.

On May 3rd, French Minister of Health François Braun announced that the government may ban disposable e-cigarettes by the end of this year.


Broun expressed his support for the ban on disposable e-cigarettes in an interview with Radio France Inter.


He added,


These devices "are leading some of our young people to use tobacco". "Smoking is a scourge, causing 75,000 deaths in France every year".


François Braun, (source of the picture: lunion)


Braun stated that despite not having a majority in the French parliament, the health ministers will "work with legislators" to reach an agreement on the ban. This ban could be implemented by "the end of this year (2023)" and will be part of the health department's "new anti-smoking plan" for the next five years.


Despite current regulations in France prohibiting the sale of electronic cigarettes to minors, critics are pointing out that about 20 brands of these products are being marketed in a way that appeals to young people. These critics claim that brightly colored packaging and affordable prices (ranging from 8-12 euros or approximately 61.1-91.7 RMB for a 500 puffs product) make the products tempting and accessible to underage buyers.


The French National Assembly recently passed a bill known as the No. 1006 Bill, which legally defines terms such as "business influence activities," "influencers," and "influencer proxies." As per the No. 96 amendment's ban on tobacco and e-cigarette promotions, France will prohibit "influential individuals" from advertising e-cigarettes.


By the end of 2022, the anti-smoking organization ACT stated that disposable vaping devices "are becoming increasingly popular on social media, with a mostly positive and harmless image among young people.


According to ACT, these disposable e-cigarettes may contain up to 20mg of highly addictive nicotine per milliliter, making them a potential "on-ramp" to smoking.


Further reading:


France prohibits influential people from advertising e-cigarettes.


The CBD market in France has reached a size of 500 million Euros and is made up of 2,000 retail stores.


ELFBAR entered the French market in February and plans to sell in 4,000 retail stores.


Reference:


The government of France is considering a prohibition of disposable e-cigarettes.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

GEEK BAR to Return to the European Market: Launches the SPARK Pod System
GEEK BAR to Return to the European Market: Launches the SPARK Pod System
GEEK BAR announced its return to the European market and the release of its pod-based product, SPARK, which will begin rolling out across select European countries starting in March. SPARK features a battery-status display interface and a fast-charging battery. It offers a 1.1Ω prefilled pod (up to approximately 1,000 puffs) and a 0.8Ω refillable pod, along with multiple new flavors tailored for Europe.
Mar.04 by 2FIRSTS.ai
PMI reshuffles South Africa leadership, appoints first female general manager
PMI reshuffles South Africa leadership, appoints first female general manager
Philip Morris International (PMI) said it has appointed Buena Barnes as general manager of its South Africa business, marking the first time a woman has held the role in the country. Barnes previously oversaw finance for Sub-Saharan Africa and has worked at GlaxoSmithKline South Africa and British American Tobacco South Africa.
Jan.19 by 2FIRSTS.ai
PMJ Expands SENTIA Tobacco Stick Lineup, Adds Blueberry Menthol Capsule Flavor
PMJ Expands SENTIA Tobacco Stick Lineup, Adds Blueberry Menthol Capsule Flavor
Philip Morris Japan (PMJ) announced that it will launch “SENTIA Purple Capsule,” the first capsule-equipped product in its SENTIA lineup dedicated to the heated tobacco “IQOS ILUMA” series, as an early release in Japan. The product will roll out nationwide starting from IQOS Stores, and will enter tobacco retail channels nationwide from April 6.
Mar.03 by 2FIRSTS.ai
Bangladesh High Court rule targets vape-ban clause; fines up to about $1,635 cited
Bangladesh High Court rule targets vape-ban clause; fines up to about $1,635 cited
Bangladesh’s High Court issued a rule asking why Section 6(G) of the Smoking and Tobacco Products Usage (Control) Act, 2005 — which bans the import, supply and sale of vapes and e-cigarettes — should not be declared unconstitutional and illegal.
Mar.02 by 2FIRSTS.ai
From Tamarind’s AI Shift to Industry Restructuring, The ‘Amazon Moment’ for Nicotine Is Approaching
From Tamarind’s AI Shift to Industry Restructuring, The ‘Amazon Moment’ for Nicotine Is Approaching
Tamarind Intelligence’s decision to appoint a technology-sector executive as chief executive officer signals more than a leadership reshuffle at a specialist data firm. It reflects a broader structural shift across the global nicotine industry, where companies, regulators and intelligence providers are embedding artificial intelligence into core operations.
Special Report
Feb.18
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
At the opening of FDA’s PMTA roundtable, small ENDS manufacturers warned that unclear product characterization standards are limiting their ability to invest and raise capital. FDA officials acknowledged industry concerns but said regulatory flexibility is constrained by statutory and procedural boundaries.
Feb.11